Results
1 -
10 of
98Rodnina et al..
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small cell lung cancer, Nature Chemical Biology, 2007 Wu et al..
Site selectivity of platinum anticancer therapeutics, Nature Chemical Biology, 2007 Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer, Gastric Cancer Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer, Surgery Today Iron- and ascorbic acid-induced lipid peroxidation in renal microsomes isolated from rats treated with platinum compounds, Cancer Chemotherapy and Pharmacology Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo, Journal of Experimental & Clinical Cancer Research Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration, Journal of Neuro-Oncology All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway, Naunyn-Schmiedeberg's Archives of Pharmacology The cytotoxic interaction of inorganic trace elements with EDTA and cisplatin in sensitive and resistant human ovarian cancer cells, In Vitro Cellular & Developmental Biology - Animal Mechanisms of Synergism Between Gemcitabine and Cisplatin, Purine and Pyrimidine Metabolism in Man IX